Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protalix BioTherapeutics (PLX) Shares Outstanding (Weighted Average) (2016 - 2025)

Protalix BioTherapeutics has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $78.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $78.5 million for Q4 2025, up 8.29% from a year ago — trailing twelve months through Dec 2025 was $78.5 million (up 8.29% YoY), and the annual figure for FY2025 was $78.5 million, up 8.29%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $78.5 million at Protalix BioTherapeutics, roughly flat from $78.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for PLX hit a ceiling of $78.7 million in Q2 2025 and a floor of $39.9 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $64.1 million (2023), compared with a mean of $61.0 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 129.76% in 2021 and later increased 4.16% in 2022.
  • Protalix BioTherapeutics' Shares Outstanding (Weighted Average) stood at $44.1 million in 2021, then increased by 9.81% to $48.5 million in 2022, then skyrocketed by 39.28% to $67.5 million in 2023, then increased by 7.43% to $72.5 million in 2024, then grew by 8.29% to $78.5 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $78.5 million (Q4 2025), $78.2 million (Q3 2025), and $78.7 million (Q2 2025) per Business Quant data.